<DOC>
	<DOCNO>NCT00524498</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy continuous hepatic arterial infusion combination therapy OPC-18 5-FU versus BST patient highly advanced hepatocellular carcinoma resection therapy local therapy inapplicable due advance vascular invasion .</brief_summary>
	<brief_title>A Phase II Study Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 5-FU Patients With Highly Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients histologically clinically ( diagnostic imaging tumor marker ) diagnose hepatocellular carcinoma Patients measurable lesion contrast CT Patients remote metastasis ( extrahepatic metastasis ) , confirm Xray , CT , MRI , mean necessary Patients previously receive intraarterial hepatic chemotherapy Patients receive herbal medicine shosaikoto Patients autoimmune hepatitis Patients history hypersensitivity OPC18 interferon preparation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>OPC-18</keyword>
	<keyword>Interferon-alpha</keyword>
	<keyword>Fluorouracil</keyword>
</DOC>